ロード中...

Established T-cell inflamed tumors rejected after adaptive resistance was reversed by combination STING activation and PD-1–pathway blockade

Patients with head and neck squamous cell carcinoma harbor T-cell inflamed and non-T-cell inflamed tumors. Despite this, only 20% of patients respond to checkpoint inhibitor immunotherapy. Lack of induction of innate immunity through pattern-recognition receptors such as the stimulator of interferon...

詳細記述

保存先:
書誌詳細
出版年:Cancer Immunol Res
主要な著者: Moore, Ellen, Clavijo, Paul E., Davis, Ruth, Cash, Harrison, Van Waes, Carter, Kim, Young, Allen, Clint
フォーマット: Artigo
言語:Inglês
出版事項: 2016
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5134907/
https://ncbi.nlm.nih.gov/pubmed/27821498
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-16-0104
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!